Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to COVID 19

CompletedOBSERVATIONAL
Enrollment

445

Participants

Timeline

Start Date

March 22, 2020

Primary Completion Date

September 1, 2020

Study Completion Date

December 8, 2020

Conditions
Covid19 and Mortality
Interventions
DIAGNOSTIC_TEST

clinical features and laboratory values

Patients' age, gender, comorbidity, ABO and Rh blood groups, APACHE II, SOFA and KDIGO scores when first admitted to the ICU, performing hemogram (WBC, neutrophil, lymphocyte, neutrophil / lymphocyte ratio, hemoglobin, hematocrit, platelet count), blood gas information (pH, PO2, PCO2, HCO3, lactate), coagulation parameters PTZ and D-dimer, blood biochemistry results (CRP, LDH, CK, urea, creatinine, ALT, AST, total bilirubin, direct bilirubin and indirect bilirubin), procalcitonin and ferritin levels will be recorded. In addition, the number of days spent in the ICU and whether mortality develops or not will be recorded.

Trial Locations (1)

Unknown

Diyarbakır Gazi Yaşargil Training and Research Hospital, Diyarbakır

All Listed Sponsors
lead

Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital

OTHER

NCT04659876 - Factors Affecting Mortality in Critical Patients Admitted to Intensive Care Unit Due to COVID 19 | Biotech Hunter | Biotech Hunter